Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DITPA in Hypercholesterolemic Patients
NCT00311987Phase 2Terminated
- Sponsor
- Johns Hopkins University
- Start
- Apr 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of 3,5-diiodothyropropionic acid in hypercholesterolemia (3 arms), sponsored by Johns Hopkins University. Primary endpoint: Proportion of patients achieving NCEP ATP III LDL-C goals at 12 weeks. Started Apr 2006; status: terminated.
02
Drugs
3,5-diiodothyropropionic acid
03
Conditions
hypercholesterolemia
Beyond the preview
Go deeper on NCT00311987.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00311987.